|本期目录/Table of Contents|

[1]李萌,闫小菊,苏亚坤,等.富含Gla蛋白水平与急性冠脉综合征患者PCI后主要不良心血管事件发生风险的关系[J].医学研究与战创伤救治(原医学研究生学报),2025,38(01):56-62.[doi:10.16571/j.cnki.2097-2768.2025.01.009]
　LI Meng,YAN Xiaoju,SU Yakun,et al.A study of the relationship between Gla-rich protein levels and the risk of major adverse cardiovascularevents after PCI in patients with acute coronary syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2025,38(01):56-62.[doi:10.16571/j.cnki.2097-2768.2025.01.009]
点击复制

富含Gla蛋白水平与急性冠脉综合征患者PCI后主要不良心血管事件发生风险的关系()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
38卷
期数:
2025年01期
页码:
56-62
栏目:
论著·临床研究
出版日期:
2025-01-20

文章信息/Info

Title:
A study of the relationship between Gla-rich protein levels and the risk of major adverse cardiovascularevents after PCI in patients with acute coronary syndrome
文章编号:
2097-2768（2025）01-0056-07
作者:
李萌; 闫小菊; 苏亚坤; 张慧晶; 曹静
作者单位：053000 衡水，衡水市人民医院心血管内科（李萌、闫小菊、苏亚坤、张慧晶、曹静）
Author(s):
LI Meng; YAN Xiaoju; SU Yakun; ZHANG Huijing; CAO Jing
（Department of Cardiology，Hengshui People’s Hospital，Hengshui 053000，Hebei，China）
关键词:
富含Gla蛋白; 急性冠状动脉综合征; 主要不良心血管事件; 诊断价值; 危险因素
Keywords:
Gla-rich protein; acute coronary syndrome; major adverse cardiovascular events; diagnostic value; risk factors
分类号:
R543.3
DOI:
10.16571/j.cnki.2097-2768.2025.01.009
文献标志码:
A
摘要:
目的 探讨血清富含Gla蛋白（GRP）水平与急性冠状动脉综合征（ACS）患者经皮冠状动脉介入治疗（PCI）后主要不良心血管事件（MACE）发生风险的关系。方法选择2020年6月至2022年1月衡水市人民医院心血管内科收治的120例ACS患者作为ACS组。根据PCI术后6个月内MACE发生情况分为MACE组（22例）和非MACE组（98例）。选择同期于本院体检的100例健康者作为对照组。收集所有受试者的临床资料。采用酶联免疫吸附法检测血清GRP水平，根据GRP水平分为低水平GRP组和高水平GRP组。绘制ROC曲线评价血清GRP诊断ACS的效能。采用Logistic回归分析影响ACS发生的风险因素。采用Kaplan-Meier法和Cox回归分析血清GRP对MACE的预测价值。结果与对照组相比，ACS组患者血清GRP水平显著降低（P<0.05）。ACS患者血清GRP水平与Gensini评分和GRACE评分均呈明显负相关（P<0.05）。血清GRP诊断ACS的AUC为0.736（95%CI：0.668~0.804），敏感性为80.00%，特异性为61.00%。GRP 水平升高是ACS 发生的独立保护因素（OR=0.334，95%CI：0.184~0.606）。与非MACE组相比，MACE组患者血清GRP水平明显降低（P<0.05）。低水平GRP组患者PCI术后MACE的发生风险明显高于高水平GRP 组（P=0.022），且血清GRP 水平升高是PCI 术后MACE 发生的独立保护因素（HR=0.347，95%CI：0.206~0.584）。血清GRP 水平与ACS 患者血清IL-1β（r=-0.271，P=0.003）、TNF- α（r=-0.481，P<0.001）、ICAM-1（r=-0.315，P=0.001）和VCAM-1（r=-0.279，P=0.002）水平均呈明显负相关。结论GRP在ACS患者血清中明显降低，可作为ACS诊断及预测PCI术后MACE发生风险的新型生物标志物。
Abstract:
Objective To investigate the relationship between serum Gla-rich protein（GRP）levels and the risk of major ad?verse cardiovascular events（MACE） after percutaneous coronary intervention （PCI） in patients with acute coronary syndrome（ACS）. Methods 120 ACS patients admitted to our hospital from June 2020 to January 2022（ACS group）were selected as studysubjects. They were divided into MACE group（22 cases）and non-MACE group（98 cases）according to the occurrence of MACE with?in 6 months after PCI. 100 cases of healthy people who underwent physical examination in our hospital during the same period were se?lected as the control group. Clinical data of all subjects were collected. Serum GRP levels were measured by enzyme-linked immunosor?bent assay and divided into low GRP group and high GRP group. ROC curves were plotted to evaluate the efficacy of serum GRP in di?agnosing ACS. Logistic regression was used to analyse the risk fac?tors affecting the occurrence of ACS. Kaplan-Meier method andCox regression were used to analyse the predictive value of serumGRP for MACE. Results Serum GRP levels were significantlylower in patients in the ACS group compared with the control group（P<0.05）. Serum GRP levels were significantly negatively correlat?ed with both Gensini score and GRACE score in patients with ACS（P<0.05）. The AUC of serum GRP for the diagnosis of ACS was 0.736（95%CI: 0.668-0.804），with a sensitivity of 80.00% and a spec?ificity of 61.00%. Elevated levels of GRP were an independent protective factor for the development of ACS（OR=0.334，95%CI:0.184-0.606，P<0.001）. Serum GRP levels were significantly lower in patients in the MACE group compared to the non-MACE group（P<0.05）. The risk of MACE after PCI was significantly higher in patients in the low-level GRP group than in the high-level GRPgroup（P=0.022），and the elevated serum GRP level was an independent protective factor for the occurrence of MACE after PCI（HR=0.347，95%CI: 0.206-0.584，P<0.001）. Serum GRP levels were significantly negatively correlated with serum IL-1β（r=-0.271，P=0.003），TNF-α（r=-0.481，P<0.001），ICAM-1（r=-0.315，P=0.001），and VCAM-1（r=-0.279，P=0.002）levels in ACS patients（P<0.05）. Conclusion GRP is significantly reduced in the serum of ACS patients and can be used as a novel biomarker for the diagno?sis of ACS and prediction of the risk of MACE after PCI.

参考文献/References:

［1］ 李建军.心血管代谢相关危险因素是心血管疾病防控的关键［J］.中国循环杂志，2022，37（10）:969-973.［2］ 袁建英，娄华聪，姜友亮，等.血清ANGPTL4，SIRT1在急性脑梗死介入治疗前后变化及与预后的关系［J］.医学研究与战创伤救治，2023，36（6）:615-618.［3］ Agwa SHA，Elzahwy SS，El Meteini MS，et al.ABHD4-Regulat?ing RNA Panel: Novel Biomarkers in Acute Coronary SyndromeDiagnosis［J］. Cells，2021，10（6）:1512.［4］ Porter A，Paradkar A，Goldenberg I，et al.Temporal Trends Anal?ysis of the Characteristics，Management，and Outcomes of Wom?en With Acute Coronary Syndrome（ACS）: ACS Israeli SurveyRegistry 2000-2016［J］. J Am Heart Assoc，2020，9（1）:e014721.［5］ Mol JQ，Belkacemi A，Volleberg RH，et al.Identification of ana?tomic risk factors for acute coronary events by optical coherencetomography in patients with myocardial infarction and residualnonflow limiting lesions: rationale and design of the PECTUSobsstudy［J］. BMJ Open，2021，11（7）:e048994.［6］ 程增为，胡司淦.富含Gla蛋白参与冠状动脉钙化机制的研究进展［J］.中国动脉硬化杂志，2023，31（1）:88-92.［7］ Silva AP，Viegas CSB，Guilherme P，et al.Gla-Rich Protein，Mag?nesium and Phosphate Associate with Mitral and Aortic ValvesCalcification in Diabetic Patients with Moderate CKD［J］. Diag?nostics（Basel），2022，12（2）:496.［8］ 闫小菊，李萌，曹静，等.血清富含Gla 蛋白水平与急性冠状动脉综合征患者冠状动脉钙化程度及预后的相关性［J］.中国老年学杂志，2024，5（44）:2057-2060［9］ 张新超，于学忠，陈凤英，等.急性冠脉综合征急诊快速诊治指南（2019）［J］.临床急诊杂志，2019（4）:10.［10］ 邵海锐，吕磊，钟勇.高温对心血管系统影响的研究进展［J］.医学研究与战创伤救治，2023，36（11）:1217-1220.［11］ 刘立新，童绥菊，袁海涛，等.急性心肌梗死合并肺部感染病原学及心肌酶谱和炎症因子变化［J］.中华医院感染学杂志，2023，33（10）:1482-1485.［12］ Zhong Z，Wu H，Zhong W，et al.Expression profiling and bioin?formatics analysis of circulating microRNAs in patients withacute myocardial infarction［J］. J Clin Lab Anal，2020，34（3）:e23099.［13］ 高雪莲，王瑞，张宏凯，等.冠状动脉CT血管造影影像组学用于冠心病研究进展［J］.中国医学影像技术，2024，40（3）:451-454.［14］ Düsing P，Zietzer A，Goody PR，et al.Vascular pathologies inchronic kidney disease: pathophysiological mechanisms and nov?el therapeutic approaches［J］. J Mol Med（Berl），2021，99（3）:335-348.［15］ 胡晓侠，黄颖，伍梦佐，等.APOA1和Genisini评分与冠状动脉粥样硬化快速进展密切相关［J］. 临床心血管病杂志，2024，40（4）:286-290.［16］ 王荣荣，田俊萍.急性冠脉综合征患者血清钙与心血管预后的关系［J］.首都医科大学学报，2023，44（1）:154-160.［17］ Demirci R，Sevinc C.The Relationship Between Carotid IntimaMedia Thickness，Inflammation and GLA Rich Protein Levels inChronic Kidney Disease［J］. Int J Gen Med，2021，14: 5119-5126.［18］ Wang J，Liu W，Chen H，et al.Novel Insights Into the InteractionBetween the Autonomic Nervous System and Inflammation onCoronary Physiology: A Quantitative Flow Ratio Study［J］. FrontCardiovasc Med，2021，8:700943.［19］ Alenazy FO，Thomas MR.Novel antiplatelet targets in the treat?ment of acute coronary syndromes［J］. Platelets，2021，32（1）:15-28.［20］ Croft DP，Cameron SJ，Morrell CN，et al.Associations betweenambient wood smoke and other particulate pollutants and bio?markers of systemic inflammation，coagulation and thrombosis incardiac patients［J］. Environ Res，2017，154:352-361.［21］ Viegas CSB，Araújo N，Carreira J，et al.Nanoencapsulation ofGla-Rich Protein（GRP）as a Novel Approach to Target Inflam?mation［J］. Int J Mol Sci，2022，23（9）:4813.

相似文献/References:

[1]周助权,汪俊军,张民军,等.C反应蛋白、心肌肌钙蛋白T和N末端B型钠尿肽原对诊断急性冠状动脉综合征的价值[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):156.
[2]郭琼.急性冠状动脉综合征患者服药信念及影响因素分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(06):604.[doi:10.3969/j.issn.1672-271X.2017.06.011]
　GUO Qiong.Belief about medicines in acute coronary syndrome patients and its influencing factors[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(01):604.[doi:10.3969/j.issn.1672-271X.2017.06.011]
[3]王静,汤沂,王磊.自发性冠状动脉夹层的诊断及救治分析并文献复习[J].医学研究与战创伤救治(原医学研究生学报),2021,23(05):489.[doi:10.3969/j.issn.1672-271X.2021.05.009]
　WANG Jing,TANG Yi,WANG Lei.Spontaneous coronary artery dissection：A case report and review of literature[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(01):489.[doi:10.3969/j.issn.1672-271X.2021.05.009]

备注/Memo

备注/Memo:
基金项目：衡水市科技计划项目（2021014086Z）
更新日期/Last Update: 2025-01-20